Literature DB >> 20568427

[Combination of acupuncture, cupping and medicine for treatment of fibromyalgia syndrome: a multi-central randomized controlled trial].

Zhen-Ya Jang1, Chang-Du Li, Ling Qiu, Jun-Hua Guo, Ling-Na He, Yang Yue, Fang-Ze Li, Wen-Yi Qin.   

Abstract

OBJECTIVE: To evaluate the clinical effect of combination of acupuncture, cupping and medicine for treatment of fibromyalgia syndrome.
METHODS: By using multi-central randomized controlled method, 186 cases were randomly divided into an acupuncture combined with cupping and western medicine group (group A), an acupuncture combined with cupping group (group B) and a western medicine group (group C) and treated continuously for 4 weeks. The treatment of acupuncture combined with cupping was produced by acupuncture at five mental points and moving cupping on the Hechelu of the back, once evrey other day, thrice each week, and the western medicine therapy by oral administration of Amitriptyline, once each day. The scores of McGill Pain Questionnaire (MPQ), the amount of tenderness point and the time of producing effect were compared and the therapeutic effects were assessed with the Hamilton Depression Scale (HAMD).
RESULTS: The cured and markedly effective rate was 65.0% (39/60) in the group A, which was superior to 15.9% (10/63) in the group B and 16.1% (9/56) in the group C (both P < 0.001). After treatment, the scores of MPQ and HAMD and the amount of tenderness point all decreased in the three groups, group A being significantly better than group B and group C, and the time of producing effect in the group A was more earlier than those in the group B and the group C.
CONCLUSION: The therapeutic effect of combination of acupuncture, cupping and medicine on fibromyalgia syndrome is superior to that of the simple acupuncture combined with cupping or the simple medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568427

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  9 in total

Review 1.  Complementary therapies for fibromyalgia syndrome -- a rational approach.

Authors:  Marcelo Saad; Roberta de Medeiros
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 2.  [Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  J Langhorst; W Häuser; K Bernardy; H Lucius; M Settan; A Winkelmann; F Musial
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 3.  [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  C Sommer; W Häuser; R Alten; F Petzke; M Späth; T Tölle; N Uçeyler; A Winkelmann; E Winter; K J Bär
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 4.  Cupping (Hijama) in Rheumatic Diseases: The Evidence.

Authors:  Georges El Hasbani; Ali Jawad; Imad Uthman
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

Review 5.  Amitriptyline for fibromyalgia in adults.

Authors:  R Andrew Moore; Sheena Derry; Dominic Aldington; Peter Cole; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2019-05-28

Review 6.  Acupuncture for treating fibromyalgia.

Authors:  John C Deare; Zhen Zheng; Charlie C L Xue; Jian Ping Liu; Jingsheng Shang; Sean W Scott; Geoff Littlejohn
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

Review 7.  Acupoint stimulation for fibromyalgia: a systematic review of randomized controlled trials.

Authors:  Huijuan Cao; Xun Li; Mei Han; Jianping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-17       Impact factor: 2.629

8.  Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Xin-Chang Zhang; Hao Chen; Wen-Tao Xu; Yang-Yang Song; Ya-Hui Gu; Guang-Xia Ni
Journal:  J Pain Res       Date:  2019-01-30       Impact factor: 3.133

9.  A randomized clinical trial of fibromyalgia treatment with acupuncture compared with fluoxetine.

Authors:  M J Hadianfard; M Hosseinzadeh Parizi
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.